Reducing Behavioral Risk Factors of NCDs: Protocol for a School-based Health Education Program in Bangladesh
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03975335|
Recruitment Status : Completed
First Posted : June 5, 2019
Last Update Posted : June 5, 2019
|Condition or disease||Intervention/treatment||Phase|
|Non-communicable Disease Risk Factors||Behavioral: Health education Other: Carrier Guidance||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||823 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||An Intervention Program to Reduce NCD Related Behavioral Risk Factor Among Adolescents in Institutional Settings of Bangladesh|
|Actual Study Start Date :||May 2, 2018|
|Actual Primary Completion Date :||August 20, 2018|
|Actual Study Completion Date :||August 20, 2018|
Experimental: Intervention group
Health education on NCDs and behavioral risk factors was delivered through motivation and observational learning session.
Behavioral: Health education
In this health education intervention, emphasis is given on evoking adolescents' internal desire to change, supporting self-efficacy to be changed, guiding self-regulatory ways along with facilitating desired changing process by empowering them with choices and skills.
Placebo Comparator: Control group
Control group received session on carrier guidance.
Other: Carrier Guidance
Carrier opportunities and counselling
- Change in knowledge [ Time Frame: Three months ]Knowledge about non-communicable diseases related risk behaviors such as dietary habit, physical activity, smoking and alcohol will be measured by 25 knowledge measuring questions scoring 54 in total. Answer to the questions will be regarded as correct or incorrect based on information from standard medical textbooks and guidelines. Difference of knowledge score from pre-intervention to post-intervention survey will be measured.
- Change in attitude [ Time Frame: Three months ]Attitude towards the risk behaviors- dietary habit, physical activity, smoking and alcohol will be measured by nine attitude measuring questions in a Likert Scale ranging from one to three. Change in attitude score from pre-intervention to post-intervention survey will be measured.
- Change in practice [ Time Frame: Three months ]
Practice will be measured as follows-
Dietary habit: Presence of at least two of the following four habits will be accounted as having dietary risk behavior.
i. Inadequate fruit consumption: Less than five servings of fruits per day ii. Inadequate vegetable consumption: Less than five servings of vegetables per day iii. Excessive salt consumption: Taking extra or raw salt during every meal iv. Sugar Sweetened Beverage (SSB) consumption: Consuming SSB more than three days per week
- Physical activity: Not meeting 60 minutes physical activity of moderate intensity per day will be regarded as physically inactive.
- Smoking and alcohol: Smoking regularly in the last 30 days or exposing to passive smoking more than three days per week will be accounted as in risk of smoking. Any amount of alcohol intake or any substance abuse in the last 30 days will be regarded as at risk.
Change in practice from pre-intervention to post-intervention survey will be measured.
- Body Mass Index (BMI) [ Time Frame: Three months ]The ratio of body weight in kilogram and the height in meter square will be considered as BMI. Classification of BMI will be done as following- Underweight (Less than 18.5); Normal weight (18.5-24.9); Overweight (25.0-29.9) and Obese (More than 30.0)
- Blood Pressure [ Time Frame: Three months ]Blood pressure will be measured by an automatic digital sphygmomanometer (HEM-8712, Omron, Kyoto, Japan). Presence of systolic blood pressure ≥ 130 mm of Hg and/or diastolic blood pressure ≥ 80 mm of Hg will be considered as having high blood pressure.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03975335
|Chi Research & Infotec Ltd.|
|Dhaka, Bangladesh, 1000|
|Principal Investigator:||Md Khalequzzaman, PhD||Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh|
|Study Director:||Sohel Reza Choudhury, DrPH||National Heart Foundation Hospital and Research Institute|